MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 591222 | Name: ADTN

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ADTN is a dopamine receptor agonist.

Chemical Structure

ADTN
CAS#53463-78-8

Theoretical Analysis

MedKoo Cat#: 591222

Name: ADTN

CAS#: 53463-78-8

Chemical Formula: C10H13NO2

Exact Mass: 179.0946

Molecular Weight: 179.22

Elemental Analysis: C, 67.02; H, 7.31; N, 7.82; O, 17.85

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
ADTN
IUPAC/Chemical Name
2,3-Naphthalenediol, 6-amino-5,6,7,8-tetrahydro-
InChi Key
ASXGAOFCKGHGMF-UHFFFAOYSA-N
InChi Code
InChI=1S/C10H13NO2/c11-8-2-1-6-4-9(12)10(13)5-7(6)3-8/h4-5,8,12-13H,1-3,11H2
SMILES Code
OC1=C(O)C=C2CC(N)CCC2=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 179.22 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Pinheiro T, Otrocka M, Seashore-Ludlow B, Rraklli V, Holmberg J, Forsberg-Nilsson K, Simon A, Kirkham M. Reprint of: A chemical screen identifies trifluoperazine as an inhibitor of glioblastoma growth. Biochem Biophys Res Commun. 2018 May 5;499(2):136-142. doi: 10.1016/j.bbrc.2018.03.001. Epub 2018 Mar 23. PubMed PMID: 29580626. 2: Pinheiro T, Otrocka M, Seashore-Ludlow B, Rraklli V, Holmberg J, Forsberg-Nilsson K, Simon A, Kirkham M. A chemical screen identifies trifluoperazine as an inhibitor of glioblastoma growth. Biochem Biophys Res Commun. 2017 Dec 16;494(3-4):477-483. doi: 10.1016/j.bbrc.2017.10.106. Epub 2017 Oct 21. PubMed PMID: 29066348. 3: Rivarola MA, Dalmasso C, Valdez DJ, Vivas LM, Suárez MM. Early maternal separation and chronic variable stress as adults differentially affect Fos expression in the anterodorsal thalami nuclei. Int J Neurosci. 2008 May;118(5):735-48. doi: 10.1080/00207450701750430. PubMed PMID: 18446587. 4: Nicola SM, Kombian SB, Malenka RC. Psychostimulants depress excitatory synaptic transmission in the nucleus accumbens via presynaptic D1-like dopamine receptors. J Neurosci. 1996 Mar 1;16(5):1591-604. PubMed PMID: 8774428. 5: Freedman SB, Patel S, Marwood R, Emms F, Seabrook GR, Knowles MR, McAllister G. Expression and pharmacological characterization of the human D3 dopamine receptor. J Pharmacol Exp Ther. 1994 Jan;268(1):417-26. PubMed PMID: 8301582. 6: Balmforth AJ, Yasunari K, Vaughan PF, Ball SG. Characterization of dopamine and beta-adrenergic receptors linked to cyclic AMP formation in intact cells of the clone D384 derived from a human astrocytoma. J Neurochem. 1988 Nov;51(5):1510-5. PubMed PMID: 2459312. 7: Laschinski G, Kittner B, Bräutigam M. Direct inhibition of tyrosine hydroxylase from PC-12 cells by catechol derivatives. Naunyn Schmiedebergs Arch Pharmacol. 1986 Apr;332(4):346-50. PubMed PMID: 2874501. 8: el-Refai MF, Chan TM. Possible involvement of a hypothalamic dopaminergic receptor in development of genetic obesity in mice. Biochim Biophys Acta. 1986 Jan 15;880(1):16-25. PubMed PMID: 3080029. 9: Berry-Kravis E, Freedman SB, Dawson G. Specific receptor-mediated inhibition of cyclic AMP synthesis by dopamine in a neuroblastoma X brain hybrid cell line NCB-20. J Neurochem. 1984 Aug;43(2):413-20. PubMed PMID: 6330299. 10: Westerink BH. Determination of normetanephrine, 3,4-dihydroxyphenylethyleneglycol (free and total), and 3-methoxy-4-hydroxyphenylethyleneglycol (free and total) in rat brain by high-performance liquid chromatography with electrochemical detection and effects of drugs on regional concentrations. J Neurochem. 1984 Apr;42(4):934-42. PubMed PMID: 6699645. 11: Paden CM, McEwen BS, Fishman J, Snyder L, DeGroff V. Competition by estrogens for catecholamine receptor binding in vitro. J Neurochem. 1982 Aug;39(2):512-20. PubMed PMID: 7086432. 12: Dyck LE. Release of radiolabeled dopamine, p-tyramine, and m-tyramine from rat striatal slices by some aminotetralins. Neurochem Res. 1981 Apr;6(4):365-75. PubMed PMID: 7266745. 13: Stoof JC, Horn AS, Mulder AH. Simultaneous demonstration of the activation of presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in vitro by N,N-dipropyl-5,6-ADTN. Brain Res. 1980 Aug 25;196(1):276-81. PubMed PMID: 7397528.